<DOC>
	<DOCNO>NCT01680250</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety Sirolimus reduce liver volume autosomal dominant polycystic kidney disease .</brief_summary>
	<brief_title>Sirolimus Massive Polycystic Liver</brief_title>
	<detailed_description>Autosomal dominant polycystic kidney disease ( ADPKD ) one common cause end stage renal disease ( ESRD ) , affect estimate 0.2 % population . Of ADPKD patient , 58 % 15-24 year , 85 % 25-34 year , 94 % 35-46 year old suffer polycystic liver addition polycystic kidney . Several anti-proliferative drug use clinical trial stop cyst growth liver kidney . Among , octreotide sirolimus show one promising drug reduce cyst volume . Sirolimus already use one potential oral immunosuppressant . Moreover , serum trough level quite easy measure . Sirolimus mTOR inhibitor proven effective reduce cyst growth animal model . However , efficacy safety well proven previous study . This open-label , prospective study evaluate effectiveness safety Sirolimus reduce cyst growth ADPKD patient massive polycystic liver .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Age 18 65 Patients diagnose ADPKD base upon unified criterion ultrasonographic diagnosis ADPKD Polycystic liver total liver volume &gt; 2500 mL symptomatic polycystic liver Estimated glomerular filtration rate ( IDMStraceable MDRD equation ) &gt; = 30 mL/min/1.73m2 Concomitant systemic renal parenchymal urinary tract disease ( random urine albumintocreatinine ratio &gt; 500 mg/g ) WBC &lt; 4,000/uL , platelet &lt; 100,000/uL , hemoglobin &lt; 10.0 g/dL Diabetes mellitus , cancer , psychiatric disorder Increased liver enzymes ( 2fold normal value ) Hypercholesterolemia ( fast cholesterol &gt; 200mg/dL ) hypertriglyceridemia ( &gt; 150 mg/dL ) control lipid lowering therapy Infection hepatitis B , C , HIV Any condition could prevent full comprehension purpose risk study Pregnant lactate woman fertile woman without effective contraception History intervention , cyst aspiration embolization past 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Total liver volume</keyword>
	<keyword>Liver cyst</keyword>
</DOC>